All lobbying filings

Kountoupes Denham Carr & Reid, LLC

Kountoupes Denham Carr & Reid, LLC filed a Q3 report for Apotex, Corp. on October 6, 2026, reporting $50,000 in lobbying income.

Lobbying for Apotex, Corp. · Generic pharmaceutical manufacturer.

As filed: KOUNTOUPES DENHAM CARR & REID, LLC for APOTEX, CORP.

All filings by Kountoupes Denham Carr & Reid, LLC · Everything Apotex, Corp. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 6, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to generic pharmaceuticals and drug shortages.

Tariff (miscellaneous tariff bills)

Issues related to tariffs and generic pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.